QGEN: Pendapatan reged perusahaan Qiagen NV

qiagen.com - logo grafis emiten QGEN

Qiagen N.V. is implementing ESG principles by reducing plastic in its test systems and optimizing logistics. The company's sales dynamics illustrate the inflow of revenue from sales, where 2.12 determines this parameter level. The business relies on the sale of closed systems and high-margin reagents. Revenue stability is ensured by a balance between equipment deliveries and the regular sale of consumables for DNA analysis.

QGEN - Dodolan perusahaan Qiagen N.V. ing rentang 04.07.2022 - 17.11.2026

Rincian metrik komprehensif lan analitis Qiagen NV (QGEN)

- rega saiki lan proyeksi nilai saham:
Ringkesan analisis perusahaan:QGEN (qiagen.com)
Produk seri Qiagen

Stable demand for DNA and RNA laboratory analysis automation drives the fundamental resilience of Qiagen N.V. (QGEN). The company's sales dynamics reflect genuine market interest in robotic sample preparation systems. This metric aggregates daily cash inflows, allowing for the verification of organic revenue growth. Abnormal stagnation of the line may signal hidden risks. This indicator serves as the basis for calculating the asset's fair market value.

Analisis perusahaan pesaing

Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan IONS|RGEN (Repligen) - Pendapatan dodolan perusahaan|Pendapatan perusahaan aviditybiosciences.com RNA|CRISPR (CRSP) - Total pendapatan perusahaan|genedx.com - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan RARE (ultragenyx.com)|BEAM: Pendapatan lan volume dodolan|Sarepta - Pendapatan dodolan perusahaan|TWST (twistbioscience.com) - Pendapatan lan volume dodolan|Volume dodolan perusahaan TXG (10x Genomics Corp)|Pendapatan lan volume dodolan NTLA|Pendapatan lan volume dodolan Stoke Therapeutics, Inc. (STOK)|Pendapatan perusahaan BioLife BLFS|WVE - Dodolan perusahaan|Maze Therapeutics Corp - Pendapatan lan volume dodolan|Sionna Pharma - Total dodolan perusahaan|Prime Medicine (PRME) - Pendapatan perusahaan|tayshagtx.com (TSHA) - Pendapatan lan volume dodolan|Pendapatan perusahaan uniQure Corp|MGTX: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RGNX|Pendapatan reged perusahaan Solid Corp|Pendapatan lan volume dodolan OCGN (ocugen.com)|PACB (Pacific Biosciences) - Pendapatan tahunan perusahaan|Benitec Biopharma Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Pendapatan perusahaan|4D Molecular Therapeutics (FDMT) - Pendapatan lan volume dodolan|LXEO (Lexeo Therapeutics, Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan korrobio.com KRRO|Dodolan perusahaan EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Volume dodolan perusahaan|Pendapatan perusahaan ProQR Therapeutics N.V. PRQR|Pendapatan reged perusahaan Codexis, Inc. (CDXS)|SGMO - Pendapatan perusahaan|nautilus.bio - Total dodolan perusahaan|Metagenomi, Inc (MGX) - Pendapatan perusahaan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan